Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul:189:114384.
doi: 10.1016/j.bcp.2020.114384. Epub 2020 Dec 24.

Targeting Akt-associated microRNAs for cancer therapeutics

Affiliations
Review

Targeting Akt-associated microRNAs for cancer therapeutics

Mir S Adil et al. Biochem Pharmacol. 2021 Jul.

Abstract

The uncontrolled growth and spread of abnormal cells because of activating protooncogenes and/or inactivating tumor suppressor genes are the hallmarks of cancer. The PI3K/Akt signaling is one of the most frequently activated pathways in cancer cells responsible for the regulation of cell survival and proliferation in stress and hypoxic conditions during oncogenesis. Non-coding RNAs are a large family of RNAs that are not involved in protein-coding, and microRNAs (miRNAs) are a sub-set of non-coding RNAs with a single strand of 18-25 nucleotides. miRNAs are extensively involved in the post-transcriptional regulation of gene expression and play an extensive role in the regulatory mechanisms including cell differentiation, proliferation, apoptosis, and tumorigenesis. The impact of cancer on mRNA stability and translation efficiency is extensive and therefore, cancerous tissues exhibit drastic alterations in the expression of miRNAs. miRNAs can be modulated by utilizing techniques such as miRNA mimics, miRNA antagonists, or CRISPR/Cas9. In addition to their capacity as potential targets in cancer therapy, they can be used as reliable biomarkers to diagnose the disease at the earliest stage. Recent evidence indicates that microRNA-mediated gene regulation intersects with the Akt pathway, forming an Akt-microRNA regulatory network. miRNAs and Akt in this network operate together to exert their cellular tasks. In the current review, we discuss the Akt-associated miRNAs in several cancers, their molecular regulation, and how this newly emerging knowledge may contribute greatly to revolutionize cancer therapy.

Keywords: Akt; Biomarkers; Cancer; MicroRNAs; RNA-therapeutics.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1.
Fig. 1.
History of miRNAs and milestones in miRNA research.
Fig. 2.
Fig. 2.
Biosynthesis of miRNA and inhibition of mRNA.
Fig. 3.
Fig. 3.
Milestones in Akt research.
Fig. 4.
Fig. 4.
Diagrammatic representation of microRNAs involved in suppression and progression of various cancers through Akt regulated pathways.

Similar articles

Cited by

References

    1. Wang JJ, Lei KF, Han F, Tumor microenvironment: recent advances in various cancer treatments, Eur. Rev. Med. Pharmacol. Sci 22 (12) (2018) 3855–3864. - PubMed
    1. Wang D, Gu J, Wang T, Ding Z, OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs, Bioinformatics 30 (15) (2014) 2237–2238. - PubMed
    1. Zhang WL, Zhao YN, Shi ZZ, Cong D, Bai YS, Lutein inhibits cell growth and activates apoptosis via the PI3K/AKT/mTOR signaling pathway in A549 human non-small-cell lung cancer cells, J. Environ. Pathol. Toxicol. Oncol 37 (4) (2018) 341–350. - PubMed
    1. Qadir MI, Usman M, Akash MSH, Transposable elements (human endogenous retroviruses) in cancer, Crit. Rev. Eukaryot. Gene Expr 27 (3) (2017) 219–227. - PubMed
    1. Ling B, Chen L, Liu Q, Yang J, Gene expression correlation for cancer diagnosis: a pilot study, Biomed. Res. Int 2014 (2014), 253804. - PMC - PubMed

Publication types

MeSH terms